{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:30:58Z","timestamp":1789731058843,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpet.2026.103805","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:39:22Z","timestamp":1767976762000},"page":"103805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhalable iguratimod-loaded nanostructured lipid carriers for asthma\u2013chronic obstructive pulmonary disease overlap management"],"prefix":"10.1016","volume":"393","author":[{"given":"Sayak","family":"Khawas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2026.103805_bib1","article-title":"Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets","volume":"358","author":"Leung","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jpet.2026.103805_bib2","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2147\/COPD.S312560","article-title":"Update on asthma-COPD overlap (ACO): a narrative review","volume":"16","author":"Mekov","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"9","key":"10.1016\/j.jpet.2026.103805_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136065","article-title":"Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis","volume":"10","author":"Alshabanat","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jpet.2026.103805_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.alit.2018.01.001","article-title":"Asthma and COPD overlap pathophysiology of ACO","volume":"67","author":"Hikichi","year":"2018","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.jpet.2026.103805_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/all.13004","article-title":"Asthma-COPD overlap syndrome (ACOS) vs \u201cpure\u201d COPD: a distinct phenotype?","volume":"72","author":"Caillaud","year":"2017","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.jpet.2026.103805_bib6","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.3390\/ijerph20043467","article-title":"Limitations in activities of daily living among older adults with COPD, asthma, or asthma-COPD overlap residing in Spain","volume":"20","author":"S\u00e1nchez Castillo","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.jpet.2026.103805_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1378\/chest.15-1055","article-title":"Defining the asthma-COPD overlap syndrome in a COPD cohort","volume":"149","author":"Cosio","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jpet.2026.103805_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/all.14483","article-title":"Characteristics of specialist-diagnosed asthma-COPD overlap in severe asthma: observations from the Korean Severe Asthma Registry (KoSAR)","volume":"76","author":"Lee","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.jpet.2026.103805_bib10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.alit.2024.11.003","article-title":"Prevalence and clinical impact of asthma-COPD overlap in severe asthma","volume":"74","author":"Wakazono","year":"2025","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.jpet.2026.103805_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3724\/abbs.2021009","article-title":"The functions of CD4 T-helper lymphocytes in chronic obstructive pulmonary disease","volume":"54","author":"Qin","year":"2022","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.jpet.2026.103805_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2017.09.002","article-title":"Macrophage polarization and allergic asthma","volume":"191","author":"Saradna","year":"2018","journal-title":"Transl Res"},{"issue":"2","key":"10.1016\/j.jpet.2026.103805_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jpet.2026.103805_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101422","article-title":"Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?","volume":"71","author":"Santoro","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.jpet.2026.103805_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12931-024-02790-6","article-title":"PPAR\u03b3 attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap","volume":"25","author":"Wan","year":"2024","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.103805_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12931-023-02527-x","article-title":"Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study","volume":"24","author":"Dey","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.jpet.2026.103805_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109704","article-title":"Molecular mechanisms and clinical application of iguratimod: a review","volume":"122","author":"Jiang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpet.2026.103805_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2020.00073","article-title":"Iguratimod as a new drug for rheumatoid arthritis: current landscape","volume":"11","author":"Xie","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2026.103805_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107596","article-title":"Iguratimod reduces B-cell secretion of immunoglobulin to play a protective role in interstitial lung disease","volume":"97","author":"Han","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jpet.2026.103805_bib20","article-title":"Iguratimod improves bleomycin-induced pulmonary inflammation and fibrosis by regulating macrophage polarization through inhibiting the TLR4\/NF-\u03baB pathway","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.jpet.2026.103805_bib21","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.12998\/wjcc.v9.i10.2181","article-title":"Iguratimod promotes transformation of mononuclear macrophages in elderly patients with rheumatoid arthritis by nuclear factor-\u03baB pathway","volume":"9","author":"Liu","year":"2021","journal-title":"World J Clin Cases"},{"issue":"1","key":"10.1016\/j.jpet.2026.103805_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2327498","article-title":"Iguratimod prevents renal fibrosis in unilateral ureteral obstruction model mice by suppressing M2 macrophage infiltration and macrophage-myofibroblast transition","volume":"46","author":"Zhou","year":"2024","journal-title":"Ren Fail"},{"issue":"6","key":"10.1016\/j.jpet.2026.103805_bib23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","article-title":"Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.jpet.2026.103805_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/a-1974-9078","article-title":"Transethosomes: a promising challenge for topical delivery short title: transethosomes for topical delivery","volume":"73","author":"Adnan","year":"2023","journal-title":"Drug Res (Stuttg)"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2026.103805_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2018.05.070","article-title":"Nanostructured lipid carriers-based drug delivery for treating various lung diseases: a state-of-the-art review","volume":"547","author":"Patil","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jpet.2026.103805_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2024.102319","article-title":"Lipid nanoparticles for pulmonary fibrosis: a comprehensive review","volume":"87","author":"Dhara","year":"2024","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jpet.2026.103805_bib27","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1007\/s00210-024-03744-x","article-title":"Efficacy of umbelliferone-loaded nanostructured lipid carrier in the management of bleomycin-induced idiopathic pulmonary fibrosis: experimental and network pharmacology insight","volume":"398","author":"Khawas","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"10.1016\/j.jpet.2026.103805_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1208\/s12249-023-02690-w","article-title":"Inhalation lenalidomide-loaded liposome for bleomycin-induced pulmonary fibrosis improvement","volume":"24","author":"Luo","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.jpet.2026.103805_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12950-022-00322-x","article-title":"Evaluation of asthma-chronic obstructive pulmonary disease overlap using a mouse model of pulmonary disease","volume":"19","author":"Jo","year":"2022","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.jpet.2026.103805_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149831","article-title":"Airway inflammation in a novel mouse model of asthma-COPD overlap induced by co-exposure to papain and tobacco smoke","volume":"709","author":"Kimura","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jpet.2026.103805_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/all.14528","article-title":"A mouse model of asthma-chronic obstructive pulmonary disease overlap induced by intratracheal papain","volume":"76","author":"Fukuda","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jpet.2026.103805_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-030-68748-9_9","article-title":"Overview on interactive role of inflammation, reactive oxygen species, and calcium signaling in asthma, COPD, and pulmonary hypertension","volume":"1304","author":"Truong","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.jpet.2026.103805_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.chest.2021.09.036","article-title":"Asthma-COPD overlap: what are the important questions?","volume":"161","author":"Leung","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jpet.2026.103805_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152673","article-title":"Mechanistic insights into iguratimod action in asthma-COPD overlap through multi-omics and in-silico modelling","volume":"784","author":"Khawas","year":"2025","journal-title":"Biochem Biophys Res Commun"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:08:17Z","timestamp":1777421297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022356526000030"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103805","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalable iguratimod-loaded nanostructured lipid carriers for asthma\u2013chronic obstructive pulmonary disease overlap management","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103805"}}